News
52m
Zacks Small Cap Research on MSNHURA: 2024 Financial ResultsHURA READ THE FULL HURA RESEARCH REPORT Operational and Financial Results On April 1st, 2025, TuHURA Biosciences, Inc.
1h
AZoLifeSciences on MSNThe Real Limitations of AI in Life SciencesArtificial intelligence offers breakthroughs in life sciences, yet issues of bias, interpretability, and ethics pose ...
Pfizer on Monday said it has discontinued development of experimental weight-loss pill danuglipron after a trial patient ...
The discovery of drug apparatus and other by-products along the Udu coastline in Macuata indicates a growing threat to the ...
Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...
Certara’s AI strategy and FDA-aligned offerings fuel growth across drug discovery and trials, with expanding margins. Read ...
However, it's possible that other drugmakers could be more interested in teaming up with Recursion with the FDA promoting the ...
Big Pharma and biotech startups alike are counting on AI to speed the process of drug discovery and make their operations ...
RedChip Companies will air interviews with Bullfrog AI Holdings, Inc. (Nasdaq:BFRG) and Connect Biopharma Holdings Limited (Nasdaq:CNTB) and on the RedChip Small Stocks, Big Moneyâ„¢ show, a sponsored ...
Bosch: Legacy Season 3, which is ten episodes long is ending next week as the seventh and eighth episode streamed on April 10 ...
Isomorphic Labs is the secretive AI life science startup spun out of Google DeepMind with the goal of solving all disease ...
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results